Replies to post #3479 on GTC Biotherapeutics (fka GTCB)

[waynebio]

Other question on value drivers (continued from end of last post)

2)
What is the probability of approval for AT3 in us for HD?
I belive past survey's put this at over 50%

3)
What is the probability of approval for AT3 in DIC in US and Europe?
I belive past survey's put this at over 50%

4)
Others of course but out of time, off to have a beer next door.

[DewDiligence]

>…assuming Dr. Cox would lose his job [in a merger] and gets no additional stock/cash grant from a company sale…<

I do not agree with the premise. What GTC does is sufficiently specialized that I envision Dr. Cox, Dr. Meade, and most of GTC’s technical staff being retained in the event of a buyout.